• AdvaMedDx Statement on FDA LDT Draft Guidance

    By: Statement | September 30, 2014

    “AdvaMedDx appreciates FDA’s release of draft guidance on a risk-based approach to the regulation of LDTs and looks forward to reviewing and providing comments. LDTs are increasingly being used to diagnose and guide the treatment of potentially life-threatening conditions.

  • AdvaMed Statement on the Launch of Open Payments

    By: Statement | September 30, 2014

    “AdvaMed supports appropriate disclosure of relationships between medical technology companies and physicians."

  • MITA, AdvaMed and MDMA Support Continued Bipartisan Efforts to Repeal the Device Tax

    By: Press Release | September 19, 2014

    “Repealing this tax will help ensure the U.S. maintains its global leadership in this high-tech manufacturing sector and advance the development of new cures and treatments,” said Stephen J. Ubl, President and CEO of AdvaMed. 

Payment Review & Alerts

The Payment & Policy Review is a new monthly communication from AdvaMed’s Payment and Health Care Delivery Policy Department that provides a short summary of important activities, reports, letters, meetings, etc. that relate to Medicare payment, coverage and quality issues.

READ MORE

  • 39th World Hospital Congress

    The IHF World Hospital Congress is that one-stop shop for the healthcare professional seeking the opportunity/environment in which to engage in a 360 degree learning and knowledge-sharing experience among pe... more

  • AdvaMed 2014

    As the premier medical technology industry event in North America, AdvaMed 2014: The MedTech Conference provides the optimal forum for U.S. and international life science associations to showcase their medical technology s... more